Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/9/2018
BeiGene and Boehringer Enter Supply Agreement for Anti-PD-1 Antibody T...
1/9/2018
CFDA Issues Guide for Development of Supplemental Drug Testing Methods
1/8/2018
TG Therapeutics and Hengrui Medicine Announce Global License Agreement...
1/8/2018
Ascentage Announces IND Acceptance by CFDA for Clinical Study of Novel...
1/8/2018
Merus and Simcere Announce Strategic Collaboration on Multiple Bispeci...
1/8/2018
NHFPC Outlines Ten Areas of Reform Action in the New Year
1/8/2018
MNCs Reorganize and Launch New Products in China
1/8/2018
CFDA Approves 29 More Medical Institutions as Designated Clinical Rese...
1/8/2018
CFDA Solicits Comments on Drug Data Management Guidelines
1/5/2018
CFDA Solicits Comments on the Draft Rules for Drug Inspection
1/5/2018
Biostage Raises $4.2M from Chinese Investor Group
1/5/2018
Cantargia Granted Chinese Patent for Antibody Treatment against IL1RAP...
1/5/2018
China-based KPB Biosciences to Move HQs to Philadelphia Area
1/4/2018
Recent Executive Moves
1/4/2018
Amendments Of Anti-Unfair Competition Law
1/4/2018
WIPO: China Leads Innovation by Quantity
1/4/2018
Roche's NDA for Breast Cancer Drug Perjeta Accepted in China
1/4/2018
Novartis Lost Gleevec Infringement Lawsuit in China against Jiangsu Ha...
1/4/2018
CFDA Approves New Once-Weekly Bydureon to Improve Glycemic Control in ...
1/4/2018
Angiochem and Xinogen Enter License Agreement for Breast Cancer Drug C...
1/3/2018
CFDA Issues Guidelines for Clinical Trials of Overactive Bladder Drugs
1/3/2018
ASLAN Pharma Acquires Global Rights for Varlitinib from Array BioPharm...
1/3/2018
CDMO CMAB Closes US$38 Million Series A Financing Round
1/3/2018
BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizu...
1/3/2018
Novartis/Alcon Tie Up with China Pioneer Pharma for Sale of Ophthalmic...
1/3/2018
Inovio Amends License Agreement with ApolloBio to Develop and Commerci...
1/3/2018
Sirona Biochem Announces SGLT2 IND Submission Milestone in China
1/2/2018
China FDA Solicits Comments on Conditional Approvals for New Drugs and...
12/29/2017
China Advances Drug Regulatory Reform amid Slowing Growth
12/29/2017
CFDA Issues Provisions for Batch Release of Biological Products
Page:
283
/
720
Total number of articles:
21580
:
[First]
[<<]
[281]
[282]
[283]
[284]
[285]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit